Endocrine Oncology Repository
Michigan Endocrine Oncology Repository (MEOR) is a platform to fuel innovative translational research. Through the tremendous support of our patients with rare endocrine tumors (adrenocortical cancer (ACC), pheochromocytoma, paraganglioma, neuroendocrine tumors) the repository is constantly growing.
MEOR contains:
Biological specimen (urine, blood, serum, tumor tissue) repository.
Endocrine Tissue Bank
The University of Michigan enjoys a long history of excellence in the treatment of rare endocrine tumors, specifically adrenal cancers as well as many other endocrine tumors of the thyroid, paraganglia, parathyroid, and pancreatic glands. Therefore, several years ago we formed an interdisciplinary alliance in our clinic to include our patients in a database and tissue repository. These efforts have been recently joined under the umbrella of Michigan Endocrine Oncology Repository (MEOR). The goal of the combined database and repository is to make combined analyses of patient data and biological specimen possible. MEOR is built as an interdisciplinary approach integrating the expertise of endocrinologists, pathologists, endocrine surgeons amongst other specialties. It will serve as a platform for basic and clinical researchers and function as a source for their research and more importantly will allow for a combination fueling true translational research as well as national and international collaborations.
Patients are approached mainly in our multidisciplinary Endocrine Oncology Clinic in the Rogel Cancer Center at the University of Michigan. We are truly thankful to all our patients, who have so far shown a great support for this enterprise. Tumor samples are in part obtained through the University of Michigan Tissue Procurement Service. MEOR is in part sponsored by the Michigan Institute for Clinical and Health Research (MICHR).